Six-month patient-reported outcome (PRO) results from AQUARiUS, a prospective, observational, multicenter phase 4 study in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving abiraterone acetate plus prednisone (AAP) or e

Affiliation auteurs!!!! Error affiliation !!!!
TitreSix-month patient-reported outcome (PRO) results from AQUARiUS, a prospective, observational, multicenter phase 4 study in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving abiraterone acetate plus prednisone (AAP) or e
Type de publicationJournal Article
Year of Publication2018
AuteursVuillemin AThiery, Poulsen MHvid, Dourthe L-M, Trepiakas R, Lagneau E, Pintus EPasquale, Beal-Ardisson D, Birtle AJane, Ploussard G, Besson H, Lukac M, Robinson P, Reid AHelen
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume36
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X